British American Tobacco (NYSE:BTI) is developing a potential vaccine grown in tobacco plants, while Medicago, a biotech firm partly owned by Philip Morris (NYSE:PM), is pursuing a similar effort, WSJ reports.
The success of BAT’s approach will depend on
whether its product elicits the appropriate immune response to protect
against future infection with the new coronavirus, said Beate Kampmann,
director of the London School of Hygiene and Tropical Medicine’s Vaccine
Centre.
“What’s promising is the scalability,” she added.
https://seekingalpha.com/news/3558452-big-tobacco-joins-hunt-for-covidminus-19-vaccine
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.